home / stock / crvs / crvs short
Short Information | Corvus Pharmaceuticals Inc. (NASDAQ:CRVS)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 453,695 |
Total Actual Volume | 2,555,218 |
Short Trends | |
---|---|
Cover Days | 20 |
Short Days | 0 |
No Change Days | 0 |
Averages | |
---|---|
Average Short Volume | 22,685 |
Average Short Percentage | 18.28% |
Is there a CRVS Short Squeeze or Breakout about to happen?
See the CRVS Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-22-2024 | $2.17 | $2.16 | $2.2 | $2.14 | 62,202 | 1,461 | 2.35% |
07-19-2024 | $2.14 | $2.18 | $2.19 | $2.1 | 78,413 | 16,134 | 20.58% |
07-18-2024 | $2.16 | $2.14 | $2.27 | $2.13 | 103,080 | 4,171 | 4.05% |
07-17-2024 | $2.3 | $2.17 | $2.31 | $2.141 | 92,921 | 16,052 | 17.27% |
07-16-2024 | $2.02 | $2.33 | $2.33 | $2 | 331,969 | 54,530 | 16.43% |
07-15-2024 | $2.03 | $2 | $2.08 | $1.96 | 168,004 | 46,374 | 27.6% |
07-12-2024 | $1.99 | $2.05 | $2.065 | $1.99 | 78,764 | 16,010 | 20.33% |
07-11-2024 | $1.94 | $1.98 | $2.04 | $1.92 | 144,522 | 40,684 | 28.15% |
07-10-2024 | $1.8 | $1.9 | $1.92 | $1.78 | 116,931 | 18,991 | 16.24% |
07-09-2024 | $1.8 | $1.81 | $1.86 | $1.77 | 224,475 | 32,794 | 14.61% |
07-08-2024 | $1.83 | $1.81 | $1.9 | $1.8 | 146,634 | 31,437 | 21.44% |
07-05-2024 | $1.8 | $1.82 | $1.8494 | $1.75 | 85,145 | 16,485 | 19.36% |
07-03-2024 | $1.8 | $1.78 | $1.84 | $1.77 | 24,068 | 8,368 | 34.77% |
07-02-2024 | $1.92 | $1.78 | $1.92 | $1.75 | 131,835 | 25,868 | 19.62% |
07-01-2024 | $1.81 | $1.85 | $1.89 | $1.7901 | 78,903 | 15,905 | 20.16% |
06-28-2024 | $1.86 | $1.82 | $1.8799 | $1.79 | 239,076 | 19,306 | 8.08% |
06-27-2024 | $2 | $1.87 | $2 | $1.85 | 182,692 | 36,822 | 20.16% |
06-26-2024 | $1.78 | $1.79 | $1.8595 | $1.78 | 50,509 | 7,069 | 14% |
06-25-2024 | $1.84 | $1.78 | $1.9 | $1.78 | 96,939 | 11,635 | 12% |
06-24-2024 | $1.83 | $1.83 | $1.92 | $1.83 | 118,136 | 33,599 | 28.44% |
News, Short Squeeze, Breakout and More Instantly...
Corvus Pharmaceuticals Inc. Company Name:
CRVS Stock Symbol:
NASDAQ Market:
Corvus Pharmaceuticals Inc. Website:
BURLINGAME, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that Richard A. Miller, M.D., president and chief executive officer, and Jeffrey Arcara, chief business officer, will conduct one-on-o...
Soquelitinib Phase 1 Randomized Trial in Atopic Dermatitis Enrolling at Multiple Centers; Potential for Early Data Before Year-End 2024 Soquelitinib Registration Phase 3 Trial in Peripheral T Cell Lymphoma Advancing Toward Initial Enrollment in Q3 2024 Interim Data from Ciforade...